Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ProPhase Labs (PRPH) Operating Income: 2010-2025

Historic Operating Income for ProPhase Labs (PRPH) over the last 16 years, with Sep 2025 value amounting to -$4.8 million.

  • ProPhase Labs' Operating Income rose 26.48% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.6 million, marking a year-over-year increase of 8.32%. This contributed to the annual value of -$38.6 million for FY2024, which is 82.04% down from last year.
  • As of Q3 2025, ProPhase Labs' Operating Income stood at -$4.8 million, which was down 22.34% from -$3.9 million recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Operating Income ranged from a high of $16.1 million in Q1 2022 and a low of -$17.3 million during Q4 2024.
  • Moreover, its 3-year median value for Operating Income was -$6.5 million (2023), whereas its average is -$6.6 million.
  • Over the last 5 years, ProPhase Labs' Operating Income had its largest YoY gain of 1,897.24% in 2021, and its largest YoY loss of 2,557.63% in 2021.
  • Quarterly analysis of 5 years shows ProPhase Labs' Operating Income stood at $13.7 million in 2021, then tumbled by 137.22% to -$5.1 million in 2022, then crashed by 115.30% to -$11.0 million in 2023, then plummeted by 57.77% to -$17.3 million in 2024, then increased by 26.48% to -$4.8 million in 2025.
  • Its last three reported values are -$4.8 million in Q3 2025, -$3.9 million for Q2 2025, and -$3.7 million during Q1 2025.